Inspire Medical Systems, Inc.
HealthcareNYSE:INSP · New York Stock Exchange
+$0.26 today
Vol 0.86M · Avg 1.12M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $98.9M |
| Short-term Investments | $184.9M |
| Receivables | $105.1M |
| Inventory | $166.2M |
| Other Current | $11.7M |
| Total Current Assets | $566.8M |
| PP&E (Net) | $123.8M |
| Long-term Investments | $115.9M |
| Tax Assets | $87.7M |
| Other Non-current | $17.3M |
| Total Non-current Assets | $344.6M |
| Total Assets | $911.4M |
Analysis
Selected assets total $911.4M for Latest. The largest visible component is Short-term Investments at $184.9M, about 20.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $104.8M -30.2% | $150.2M -19.1% | $185.5M -58.0% | $441.6M +105.9% | $214.5M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $203.5M -31.1% | $295.4M +7.5% | $274.8M +2698.5% | $9.8M | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $119.7M +28.6% | $93.1M +3.5% | $89.9M +46.8% | $61.2M +79.1% | $34.2M | $533.8M | $399.4M | -$1.7B |
| Inventory | $145.3M +81.3% | $80.1M +136.4% | $33.9M +185.1% | $11.9M -31.0% | $17.2M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $10.4M -13.9% | $12.1M +25.8% | $9.6M +74.3% | $5.5M | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $583.7M -7.5% | $630.8M +6.2% | $593.7M +12.0% | $530.0M +97.4% | $268.5M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $121.4M +27.5% | $95.2M +52.0% | $62.7M +159.7% | $24.1M +47.1% | $16.4M | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $96.3M +35.7% | $71.0M +676.5% | $9.1M | $0 -100.0% | $9.9M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $99.8M | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $6.1M -46.3% | $11.3M +0.6% | $11.3M +5.3% | $10.7M +5152.5% | $204.0K | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $323.7M +82.3% | $177.6M +113.8% | $83.1M +138.4% | $34.8M +31.3% | $26.5M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $907.3M +12.2% | $808.4M +19.4% | $676.8M +19.8% | $564.9M +91.4% | $295.1M | $13.3B | $11.9B | $10.6B |
| Account Payables | $36.6M -5.5% | $38.7M -0.4% | $38.8M +44.7% | $26.8M +130.2% | $11.7M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $0 | $0 | $0 | $0 -100.0% | $9.2M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $1.6M +179.4% | $577.0K | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $8.4M | $0 | $0 | $0 | $0 | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $96.1M +8.5% | $88.5M +13.3% | $78.1M +27.7% | $61.2M +48.1% | $41.3M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $0 | $0 | $0 -100.0% | $7.5M -52.3% | $15.8M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $104.0K -29.7% | $148.0K -89.0% | $1.3M +118.2% | -$7.4M -5614.9% | $134.0K | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $30.1M -0.3% | $30.2M +15.3% | $26.2M +241.0% | $7.7M -68.9% | $24.7M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $126.2M +6.3% | $118.7M +13.8% | $104.3M +51.4% | $68.9M +4.3% | $66.0M | $14.7B | $3.7B | $9.6B |
| Common Stock | $29.0K -3.3% | $30.0K +0.0% | $30.0K +3.4% | $29.0K +7.4% | $27.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$146.5M +49.8% | -$291.9M +15.5% | -$345.4M -6.5% | -$324.3M -16.1% | -$279.4M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $464.0K -13.4% | $536.0K -33.0% | $800.0K +1030.2% | -$86.0K -56.4% | -$55.0K | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $781.2M +13.3% | $689.7M +20.5% | $572.5M +15.4% | $496.0M +116.6% | $229.0M | $9.1B | $7.7B | $3.3B |
| Total Debt | $32.2M +1.1% | $31.8M +28.0% | $24.8M +51.4% | $16.4M -51.9% | $34.1M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$72.7M +38.6% | -$118.4M +26.3% | -$160.7M +62.2% | -$425.2M -135.7% | -$180.4M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Brookdale Senior Living Inc.
NYSE:BKD
$3.21B
Integer Holdings Corporation
NYSE:ITGR
$3.09B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.40B
Premier, Inc.
PINC
$2.34B
89bio, Inc.
ETNB
$2.20B
LeMaitre Vascular, Inc.
NASDAQ:LMAT
$2.10B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.46B
Ardent Health Partners, LLC
NYSE:ARDT
$1.34B
Artivion, Inc.
NYSE:AORT
$975.72M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does INSP have?
Inspire Medical Systems, Inc. (INSP) reported $104.81M in cash and equivalents in fiscal 2025.
How much debt does INSP carry?
Inspire Medical Systems, Inc. (INSP) reported $32.16M of total debt, with net debt of -$72,658,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.